News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LCA-Vision Reports 4% Increase in Third Quarter 2013 Procedures



10/2/2013 6:10:22 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

CINCINNATI, Oct. 2, 2013 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 11,932 procedures were performed during the third quarter of 2013, an increase of 4% from 11,510 procedures performed during the third quarter of 2012.

LCA-Vision will release third quarter 2013 financial results prior to the market open on Tuesday, October 29, 2013, with a conference call and webcast to follow at 10:00 a.m. Eastern time.

To access the conference call, dial 866-322-1352 (within the United States and Canada) or 706-643-6246 (international callers). The webcast will be available at the investor relations section of LCA-Vision's website. A replay of the call and webcast will begin approximately two hours after the live call has ended. To access the replay, dial 855-859-2056 (within the United States and Canada) or 404-537-3406 (international callers) and enter the conference ID number: 68999720.

About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 59 LasikPlus® vision centers in the United States: 51 full-service LasikPlus® fixed-site laser vision correction centers and eight pre- and post-operative LasikPlus® satellite centers. Since U.S. approval, more than 1.3 million laser vision correction procedures have been performed at the company's vision centers.

For Additional Information

Company Contact:

Investor Relations Contact:

Barb Kise, LCA-Vision

Jody Cain, LHA

513-792-9292

310-691-7100


@LHA_IR_PR

SOURCE LCA-Vision Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES